ASH 2022 SubQ Isatuximab + Carfilzomib & Dexamethasone in Relapsed MM: Ikema Subgroup Analysis by Number of Prior Lines of Treatment

162 views
January 4, 2023
0 Comments
Login to view comments. Click here to Login